The recommended dosefor the treatment of osteoarthritisis 200 mg per day, if necessary, your doctor may increase it up to a maximum of 400 mg.
The dose is usually:
·one 200 mg capsule once a day.
·or 100 mg twice a day
The recommended dosefor the treatment of rheumatoid arthritisis 200 mg per day (taken in twotimes),whichmaybeincreasedbyyour doctor up to a maximum of 400 mg (taken in twotimesperday),ifnecessary.
The recommended dosefor the treatment of ankylosing spondylitisis 200 mg per day,whichmaybeincreasedbyyour doctor up to a maximum of 400 mg,ifnecessary.
The dose is usually:
The initialrecommendeddoseof200 mg (taken as a 100 mg capsule twice a day) cannotbeadministeredwith CelecoxibAlmus200 mg hard capsules. Please consult your doctor.
Patientswithkidney or liver problems:make sure your doctor knows if you have liver or kidney problems since you may need a lower dose.
Patients over 65 years old, especially those weighing less than 50 kg:your doctor may want to monitor you more closely if you are over 65 years old and especially if you weigh less than 50 kg.
You should not take more than 400 mg per day.
Use in children:celecoxib is only for adults, not indicated in children.
If you take more CelecoxibAlmusthan you should
You should not take more capsules than indicated by your doctor. If you take more celecoxib than you have been told, consult your doctor, pharmacist, or hospital immediately and bring the medication with you.
You can also call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take CelecoxibAlmus
If you forget to take a capsule, take it as soon as you remember. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with CelecoxibAlmus
Stopping treatment abruptly with celecoxib may cause a worsening of symptoms. Do not stop taking celecoxib unless your doctor tells you to. Your doctor will indicate that you should reduce the dose over a few days before stopping treatment completely.
If you have any other doubts about the use of this product, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
The side effects listed below were observed in patients with arthritis who took Celecoxib Almus. The side effects marked with an asterisk (*) occurred in patients taking celecoxib for the prevention of colon polyps and have been classified according to the highest frequency of occurrence. Patients included in these studies took celecoxib at high doses and for a prolonged period.
If you experience any of the following side effects, discontinue treatment with Celecoxib Almus and inform your doctor immediately:
If you have:
Side effectsVery common(may affect more than 1 in 10 patients)
Side effectsCommon(may affect up to 1 in 10 patients)
Side effectsRare(may affect up to 1 in 1,000 patients)
Side effectsVery rare(may affect up to 1 in 10,000 patients)
Side effects ofUnknown frequency(their frequency cannot be estimated from available data)
The side effects reported in clinical trials in which celecoxib was administered at a dose of 400 mg per day for more than 3 years in patients with non-arthritis-related diseases or other arthritic conditions were:
Common(may affect up to 1 in 10 patients)
Rare(may affect up to 1 in 100 patients)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the national notification system:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keepthismedicationout of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging, after “CAD”. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at theSIGREcollection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medications. By doing so, you will help protect the environment.
Celecoxib Almus Composition
The active ingredient is celecoxib. Each hard capsule contains 200 mg of celecoxib.
The other components (excipients) are:
Lactose monohydrate, sodium lauryl sulfate, povidone, sodium croscarmellose, magnesium stearate (E572) (granulated)
Gelatin (E441), titanium dioxide (E171), iron oxide yellow (172) (capsule coating)
Shellac lacquer (E904), propylene glycol (E1520), iron oxide yellow (172) (ink)
Product appearance and packaging contents
Hard gelatin capsules, white and opaque. The capsule body contains a yellow band and on the body is printed “C90X-200” in white.
The capsules are presented in PVC/Aluminium blisters.
Packaging with 1, 10, 20, 30, 40, 50, 60, and 100 hard capsules.
Only some packaging sizes may be marketed.
Marketing Authorization Holder
Almus Farmacéutica, S.A.U.
Marie Curie, 54
08840 Viladecans (Barcelona), Spain
Phone: 93 739 71 80
Email:[email protected]
Responsible for manufacturing
Synthon Hispania S.L.
Castelló, 1,
08830 Sant Boi de Llobregat,
Spain
Synthon BV
Microweg 22
6545 CM, Nijmegen
Netherlands
EGIS PHARMACEUTICALS PLC.
Bökenyföldi ut 118-120
H-1165 Budapest, Hungary
Lek Pharmaceuticals d.d.
Verovfkova 57
SI – 1526 Ljubljana
Slovenia
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179, Barleben, Saxony-Anhalt
Germany
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Netherlands:Bixocel 200 mg, capsules,hard
Germany:Celecox-HEXAL 200 mg Hartkapseln
France:Celecoxib Sandoz 200 mg, gélule
Spain:Celecoxib Almus 200 mg hard capsules EFG
Portugal:CelecoxibSandoz
Last review date of this leaflet:July 2023
The detailed and updated information of this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.